P70 | NOVEL MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE CARE PATHWAY FOR THE EARLY DETECTION OF M PROTEIN RELATED DISEASES

Due to the greater awareness of rare diseases that are related to a even small amount of M-protein, the number of patient referrals for M-protein analysis to the hematology outpatient clinic of hospitals in the Netherlands has increased. In order to analyze all these patients in a proper way, a med...

Full description

Bibliographic Details
Published in:	Haematologica
Main Authors:	M. Minnema, F. Verheij, J. Kortleve, K. Aarsman, R. Blommers, R. Oostvogels, P. Westerweel
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2026-04-01
Online Access:	https://haematologica.org/article/view/14079

Similar Items

The significance of monoclonal gammopathy of undetermined significance
by: Robert A. Kyle, et al.
Published: (2009-12-01)

Prognostic factors in monoclonal gammopathy of undetermined significance
by: Federico Sackmann, et al.
Published: (2008-01-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
by: Melissa A. Lyle, et al.
Published: (2022-01-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Screening for monoclonal gammopathies of undetermined significance: A prospective study
by: Aissam El Maataoui, et al.
Published: (2025-03-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Seek and ye shall find: monoclonal gammopathy of undetermined significance
by: Luz Tarín-Arzaga, et al.
Published: (2023-04-01)

Necrotising fasciitis in a patient with monoclonal gammopathy of undetermined significance
by: John X. Vella, et al.
Published: (2019-07-01)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
by: Hilary C. Tanenbaum, et al.
Published: (2023-03-01)

IgM monoclonal gammopathy of undetermined significance: clinicopathologic features with and without IgM-related disorders
by: Frido K. Bruehl, et al.
Published: (2023-04-01)

Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights
by: Anastasios Tentolouris, et al.
Published: (2023-12-01)

Xanthogranuloma necrobioticum in the course of monoclonal gammopathy of undetermined significance and idiopathic neutropenia
by: Urszula Maińska, et al.
Published: (2023-04-01)

Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
by: Sigurdur Y. Kristinsson, et al.
Published: (2012-06-01)

Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
by: Elizabeth K. O’Donnell, et al.
Published: (2025-04-01)

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
by: Marzia Varettoni, et al.
Published: (2017-12-01)

IgA Monoclonal Gammopathy of Undetermined Significance and Complication of Streptococcus mitis Bacteremia
by: Jennifer Paterno, et al.
Published: (2020-01-01)

Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance
by: Leandro S. Thiago, et al.
Published: (2014-01-01)

Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
by: Kyle Robert, et al.
Published: (2010-10-01)

Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.
by: Francisca Barceló, et al.
Published: (2015-01-01)

Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by: Karina P. Verma, et al.
Published: (2023-11-01)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Pak Lok Ivan Yu, et al.
Published: (2019-07-01)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
by: Saemundur Rognvaldsson, et al.
Published: (2021-12-01)

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions
by: Valeria Ferla, et al.
Published: (2024-07-01)

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: İrem Şahver İşgör, et al.
Published: (2022-11-01)

Unusual Spherical Bodies in Bone Marrow of a Patient with Monoclonal Gammopathy of Undetermined Significance
by: Habib Moshref Razavi
Published: (2021-06-01)

Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis
by: Amalia Peix, et al.
Published: (2025-09-01)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study
by: Sæmundur Rögnvaldsson, et al.
Published: (2024-11-01)

Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance
by: Kosima Zuern, et al.
Published: (2024-08-01)

Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
by: Alexander J. Ryu, et al.
Published: (2023-02-01)

The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
by: Zhigang Yi, et al.
Published: (2022-07-01)

Monoclonal Gammopathy of Undetermined Significance with Three Bands on Serum Protein Electrophoresis: An Atypical Presentation
by: Rashmi Rasi Datta, et al.
Published: (2023-06-01)

Living kidney donor with monoclonal gammopathy of undetermined significance: Is it a contraindication for kidney donation?
by: Vinay Rathore, et al.
Published: (2019-01-01)

Concurrent Monoclonal Gammopathy of Undetermined Significance in a Patient With Maxillary Sinus Fungus Ball
by: Kyung Soo Kim MD, PhD, et al.
Published: (2025-03-01)

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA
by: Ronald S. Go, et al.
Published: (2018-03-01)

IgM monoclonal gammopathies of clinical significance: diagnosis and management
by: Jahanzaib Khwaja, et al.
Published: (2022-06-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Monoclonal gammopathy of undetermined significance with associated necrotizing myopathy: a case report and review of the literature
by: Anna Bode, et al.
Published: (2025-04-01)